• Advanced or metastatic non-small lung cancer (NSCLC)
• Advanced or metastatic pancreatic cancer

Erlonat 150mg Tablet prevents the activity of a protein called epidermal growth factor receptor (EFGR), a protein involved in the spread and growth of cancer cells.

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Erlonat150 mg tablet and cause undesirable side effects. 

Keep out of sight and reach of children. Store at a controlled room temperature between 15°C to 30°C. Do not freeze.

Always take this medicine as prescribed by the doctor. The tablet must be taken at least one hour before or two hours after taking food. Contact your doctor if you missed the dose or taken more.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

Serious:

• Persistent or severe diarrhea
• Pain in the eye, blurred vision
• sudden difficulty in breathing accompanied by cough and fever
• severe pain in your abdomen
• liver failure

Common:

• Rash, worsened in sun-exposed areas
• Loss of appetite decreased weight
• Infection
• Headache, changes in skin sensation
• Depression
• Nausea
• Mouth irritation
• Indigestion, stomach pain, the buildup of gas
• Hair loss, dry skin, itching
• Tiredness, fever
• Abnormal liver function
• Inflammation around fingernail
• acne, cracked skin
• bleeding from nose, stomach, intestines
• reduced kidney function

Inform the doctor if the patient has vision problems, use of contact lenses, clotting disorders, intolerance to sugar, and medication is taken for cholesterol before starting this medication. This medication should not be taken along with the food, and it can be taken either before or after food as it increases the effectiveness of the medication. It is not recommended for individuals below 18 years of age. Inform the doctor about kidney and liver disorders, as this medication is not recommended in patients with kidney and liver disorders. Avoid making plans to have children or during pregnancy because this medicine is highly unsafe and causes harmful effects on the developing baby. 

1. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines, 12th edition, 2011, 1735-1737.
2. Mylan, Electronic medicines compendium (emc), [ Revised on Jan 2020] [ Accessed on 14th April 2021], https://www.medicines.org.uk/emc/files/pil.11264.pdf
3. Genentech, US Food and Drug Administration, [ Revised on April 2010] [ Accessed on 14th April 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021743s14s16lbl.pdf